Grail, Inc. (NASDAQ:GRAL) CEO Sells $1,730,825.08 in Stock

Grail, Inc. (NASDAQ:GRAL) CEO Robert P. Ragusa sold 123,454 shares of the stock in a transaction dated Tuesday, October 15th. The shares were sold at an average price of $14.02, for a total value of $1,730,825.08. Following the sale, the chief executive officer now owns 612,661 shares of the company’s stock, valued at $8,589,507.22. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Grail Price Performance

NASDAQ GRAL opened at $14.20 on Friday. Grail, Inc. has a fifty-two week low of $12.33 and a fifty-two week high of $23.36. The stock has a 50 day simple moving average of $14.21.

Grail (NASDAQ:GRAL) last released its quarterly earnings data on Tuesday, August 13th. The company reported ($5.30) earnings per share for the quarter. The business had revenue of $31.97 million during the quarter.

Analyst Upgrades and Downgrades

Separately, Guggenheim initiated coverage on Grail in a report on Thursday. They set a “neutral” rating for the company.

About Grail

GRAIL, Inc, a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer.